Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study. - Takamatsu Y; Horimoto Y; Miyoshi Y; Watanabe J; Kutomi G (International journal of clinical oncology, 2026)